Smoking cessation improves insulin sensitivity in healthy middle-aged men

European Journal of Clinical Investigation

Volumn 27, Issue 5, 1997, Pages 450-456

  Eliasson, B ^a   Attvall, S ^a   Taskinen, M R ^b   Smith, U ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Apoprotein; C peptide; cigarette smoking; fibrinogen; insulin; insulin resistance; insulin resistance syndrome; lipoprotein; plasminogen activator inhibitor I activity

Indexed keywords

APOPROTEIN; C PEPTIDE; FIBRINOGEN; HUMAN INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1;

ADULT; ANTHROPOMETRY; ARTICLE; BODY WEIGHT; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; FOLLOW UP; HUMAN; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MALE; PRIORITY JOURNAL; SMOKING CESSATION; SMOKING HABIT;

EID: 0030979335     PISSN: 00142972     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1997.1330680.x     Document Type: Article

References (58)

1. Welin L, Eriksson H, Larsson B, Svärdsudd K, Wilhelmsen L, Tibblin G. Risk factors for coronary heart disease during 25 years of follow-up: the study of men born in 1913. Cardiology 1993;82:223-8.
2. Rimm EB, Manson JE, Stampfer MJ et al. Cigarette smoking and the risk of diabetes in women. Am J Public Health 1993;83:211-4.
3. Feskens EJM, Kromhout D. Cardiovascular risk factors and the 25-year incidence of diabetes mellitus in middle-aged men. The Zutphen study. Am J Epidemiol 1989;130:1101-8.
4. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ 1995;310:555-9.
5. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 1995;310:560-4.
6. Attvall S, Fowelin J, Lager I, von Schenck H, Smith U. Smoking induces insulin resistance. A potential link with the insulin resistance syndrome. J Intern Med 1993;233:327-32.
7. Frati AC, Iniestra F, Raul Ariza C. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996;19:112-8.
8. Craig WY, Palomaki GE, Haddow JE. Cigarette smoking and serum lipid and lipoprotein concentrations: an analysis of published data. BMJ 1989;298:784-8.
9. Axelsen M, Eliasson B, Joheim T, Lenner R, Taskinen M-R, Smith U. Lipid intolerance in smokers. J Intern Med 1995;237:449-55.
10. Facchini FS, Hollenbeck CB, Jeppesen J, Chen Y-DI, Reaven GM. Insulin resistance and cigarette smoking. Lancet 1992;339:1128-30.
11. Eliasson B, Mero N, Taskinen M-R, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; (in press).
12. Eliasson B, Attvall S, Taskinen MR, Smith U. The insulin resistance syndrome in smokers is related to smoking habits. Arterioscler Thromb 1994;14:1946-50.
13. Eliasson B, Taskinen M-R, Smith U. Long-term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996;94:878-81.
14. Doll R, Peto R, Wheatley K, Gray R, Sutherland I. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994;309:901-11.
15. Kawachi I, Colditz GA, Stampfer MJ et al. Smoking cessation in relation to total mortality rates in women. A prospective cohort study. Ann Intern Med 1993;119:992-1000.
16. Ernst E, Matrai A. Abstention from chronic cigarette smoking normalizes blood rheology. Atherosclerosis 1987;64:75-7.
17. Rabkin SW. Effect of cigarette smoking cessation on risk factors for coronary atherosclerosis. A control clinical trial. Atherosclerosis 1984;53:173-84.
18. Stubbe I, Eskilsson J, Nilsson-Ehle P. High-density lipoprotein concentrations increase after stopping smoking. BMJ 1982;284:1511-3.
19. Shimokata H, Muller DC, Andres R. Studies in the distribution of fat: effects of cigarette smoking. JAMA 1989;261:1169-73.
20. Lissner L, Bengtsson C, Lapidus L, Björkelund C. Smoking initiation and cessation in relation to body fat distribution based on data from a study of Swedish women. Am J Public Health 1992;82:273-5.
21. Moffatt RJ, Owens SG. Cessation from cigarette smoking: changes in body weight, body composition, resting metabolism and energy consumption. Metabolism 1991;40:465-70.
22. Hall SM, McGee R, Tunstall C, Duffy J, Benowitz N. Changes in food intake and activity after quitting smoking. J Consult Clin Psychol 1989;57:81-6.
23. Rodin J. Weight change following smoking cessation: the role of food intake and exercise. Addict Behav 1987;12:303-17.
24. Gerace TA, Hollis J, Ockenc JK, Svendsen K. Smoking cessation and change in diastolic blood pressure, body weight, and plasma lipids. Prev Med 1991;20:602-20.
25. Carney RM, Goldberg AP. Weight gain after cessation of cigarette-smoking. A possible role for adipose-tissue lipoprotein lipase. N Engl J Med 1984;310:614-6.
26. Green MS. Jucha E, Luz Y. Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 1986;111:932-9.
27. Hansen KW, Pedersen MM, Christiansen JS, Mogensen CE. Night blood pressure and cigarette smoking: disparate association in healthy subjects and diabetic patients. Blood Press 1994:3:381-8.
28. Seltzer CC. Effect of smoking on blood pressure. Am Heart J 1974;87:558-64.
29. WHO Reports. Measuring obesity-classification and description of anthropometric data. Report on a WHO consultation on the epidemiology of obesity. Warsaw: WHO, 1987:2-7.
30. Sköldborn H, Arvidsson B, Andersson M. A new whole body monitoring laboratory. Acta Radiol 1972;233-41.
31. Forbes GB, Gallup J, Hursh JB. Estimation of total body fat from potassium-40 content. Science 1961;133:101-2.
32. Attvall S, Fowelin J, von Schenck H, Smith U, Lager I. Insulin-antagonistic effects of pulsatile and continuous glucagon infusions in man. A comparison with the effect of adrenaline. J Clin Endocrinol Metab 1992;74:1110-5.
33. Liu D, Moberg E, Kollind M, Lins P-E, Adamsson U, Macdonald IA. Arterial, arterialized venous, venous and capillary blood glucose measurements in normal man during hyperinsulinemic euglycaemia and hypoglycemia. Diabetologia 1992;35:287-90.
34. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:E214-23.
35. Lager I, Attvall S, Eriksson BM, von Schenck H, Smith U. Studies on the insulin-antagonistic effect of catecholamines in normal man. Evidence for the importance of β2-receptors. Diabetologia 1986;29:409-16.
36. Ashworth L, Gibb I, Alberti KGMM. Hemocue: evaluation of a portable photometric system for determining glucose in whole blood. Clin Chem 1992;38:1479-82,
37. Huttunen JK, Ehnholm C, Kinnunen PJ, Nikkilä EA. An immunochemical method for selective measurement of two triglyceride lipases in human postheparin plasma Clin Chim Acta 1975;63:335.
38. Clauss A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol 1957;17:237-46.
39. Curvall M, Kazemi-Vala E, Enzell CR. Simultaneous determination of nicotine and cotinine in plasma using capillary column gas chromatography with nitrogen-sensitive detection. J Chromatogr 1982;232:283-93.
40. Grassi G, Seravalle G, Calhoun DA et al. Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994;90:248-53.
41. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 1988;319:1318-30.
42. Cryer PE, Haymond MW, Santiago JV, Shah SD. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 1976;295:573-7.
43. Smith U, Attvall S, Eriksson J, Fowelin J, Lönnroth P, Wesslau C. The insulin-antagonistic effect of the counterregulatory hormones. Clinical and mechanistic aspects. In: Ostenson CG, Efendic S, Vranic M, eds. New concepts in the pathogenesis of NIDDM. New York: Plenum Press, 1992:169-80. Advances in experimental medicine and biology; vol. 334.
44. Reaven GM. Role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
45. Blair SN, Kampert JB, Kohl HW, III, Barlow CE, Macera CA, Paffenberger RS, Gibbons LW. Influences of cardiorespiratory fitness and other precursors on cardiovascular disease and all-cause mortality in men and women. JAMA 1996;276:205-10.
46. 46 Hofstetter A, Schutz Y, Jéquier E, Wahren J. Increased 24-hour energy expenditure in cigarette smokers. N Engl J Med 1986;314:79-82.
47. Stamford BA, Matter S, Fell RD, Papanek P. Effects of smoking cessation on weight gain, metabolic rate, caloric consumption and blood lipids. Am J Clin Nutr 1986;43:486-94.
48. Quensel M, Söderström A, Agardh CD, Nilsson-Ehle P. High density lipoprotein concentrations after cessation of smoking: the importance of alterations in diet. Atherosclerosis 1989;75:189-93.
49. Hollenbeck CB, Collision AM. Effects of dietary carbohydrate and fat intake on glucose and lipoprotein metabolism in individuals with diabetes mellitus. Diabetes Care 1991;14:774-85.
50. Reaven GM. How high the carbohydrate? Diabetologia 1980;19:409-13.
51. Facchini F, Chen Y-DI, Reaven GM. Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 1994;17:115-9.
52. Mayer EJ, Newman B, Quesenberry CP, Friedman GJ, Selby JV. Alcohol consumption and insulin concentrations. Role of insulin in associations of alcohol intake with high-density lipoprotein cholesterol and triglycerides. Circulation 1993;88:2190-7.
53. Brunzell JD, Goldberg AP, Schwartz RS. Cigarette smoking and adipose tissue lipoprotein lipase. Int J Obesity 1980;4:101-3.
54. Chajek-Shaul, Berry EM, Ziv E, Friedman G, Stein O, Sherer G, Stein Y. Smoking depresses adipose lipoprotein lipase response to oral glucose. Eur J Clin Invest 1990;20:299-304.
55. Neese RA, Benowitz NL, Hoh R, Faix D, LaBua A, Pun K, Hellerstein MK. Metabolic interactions between surplus dietary energy intake and cigarette smoking or its cessation. Am J Physiol 1994;267:E1023-34.
56. Hellerstein MK, Benowitz NL, Neese RA et al. Effects of cigarette smoking and its cessation on lipid metabolism and energy expenditure in heavy smokers. J Clin Invest 1994;93:265-72.
57. Moriguchi EH, Fusegawa Y, Tamachi H, Goto Y. Effects of smoking on HDL subfractions in myocardial infarction patients: effects on lecithin-cholesterol acyltransferase and hepatic lipase. Clin Chim Acta 1991;195:139-43.
58. Dullaart RP, Hoogenberg K, Dikkeschei BD, van Tol A. Higher plasma lipid transfer protein activities and unfavorable lipoprotein changes in cigarette-smoking men. Arterioseler Thromb 1994;14:1581-5.